VEGF can produce different isoforms through mRNA splicing including VEGFA-165b [25], which is believed to be an anti-angiogenetic factor and downregulated in RCC, prostate cancer, colorectal cancer and melanoma [26–29]. This evidence concerns the gene VEGFA and renal cell carcinoma.